换一批
换一批Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
作者：
主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);细胞增殖(Cell Proliferation);药物协同作用(Drug Synergism);女(雌)性(Female);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);干扰素α(Interferon-alpha);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);丝裂原活化蛋白激酶1(Mitogen-Activated Protein Kinase 1);丝裂原活化蛋白激酶3(Mitogen-Activated Protein Kinase 3);喹唑啉类(Quinazolines);信号传导(Signal Transduction);肿瘤细胞, 培养的(Tumor Cells, Cultured);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/1078-0432.CCR-05-1671
PMID
16428508
发布时间
2022-03-11
- 浏览30
Clinical cancer research
617-25页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
